Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5105)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Jun 11, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sibio MTD, Oliveira M, Moretto FCF, Olimpio RMC, Conde SJ, Luvizon AC, Nogueira CR. Triiodothyronine and breast cancer. World J Clin Oncol 2014; 5(3): 503-508 [PMID: 25114863 DOI: 10.5306/wjco.v5.i3.503] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/503.htm |
| Number | Citing Articles |
| 1 |
Graham P. Leese, Enrique Soto‐Pedre, Louise A. Donnelly. Liothyronine use in a 17 year observational population‐based study ‐ the tears study. Clinical Endocrinology 2016; 85(6): 918 doi: 10.1111/cen.13052
|
| 2 |
Rainer H. Straub, Manfred Schedlowski. Kompendium Internistische Onkologie. Springer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-46764-0_57-1
|
| 3 |
Katarzyna J. Jerzak, Jessica Cockburn, Gregory R. Pond, Kathleen I. Pritchard, Steven A. Narod, Sukhbinder K. Dhesy-Thind, Anita Bane. Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. Breast Cancer Research and Treatment 2015; 149(1): 293 doi: 10.1007/s10549-014-3235-9
|
| 4 |
Enke Baldini, Augusto Lauro, Domenico Tripodi, Daniele Pironi, Maria Ida Amabile, Iulia Catalina Ferent, Eleonora Lori, Federica Gagliardi, Maria Irene Bellini, Flavio Forte, Patrizia Pacini, Vito Cantisani, Vito D’Andrea, Salvatore Sorrenti, Salvatore Ulisse. Thyroid Diseases and Breast Cancer. Journal of Personalized Medicine 2022; 12(2): 156 doi: 10.3390/jpm12020156
|
| 5 |
N. S. Pidchenko. The use of L-thyroxine in the treatment of thyroid pathologies and problems of therapy control (literature review). Український радіологічний та онкологічний журнал 2020; 28(4): 387 doi: 10.46879/ukroj.4.2020.387-402
|
| 6 |
Zongyi Wang, Yulu Wang, Fangfang Lv, Xiaoyu Liu, Changxi Jia, Xiangning Chen, Tao Han. An Effective Method for Monitoring Three Iodothyronines in Meat Tissue and Eggs by Liquid Chromatography–Tandem Mass Spectrometry. Food Analytical Methods 2015; 8(8): 2069 doi: 10.1007/s12161-015-0091-0
|
| 7 |
Iuri Martin Goemann, Vicente Rodrigues Marczyk, Mirian Romitti, Simone Magagnin Wajner, Ana Luiza Maia. Current concepts and challenges to unravel the role of iodothyronine deiodinases in human neoplasias. Endocrine-Related Cancer 2018; 25(12): R625 doi: 10.1530/ERC-18-0097
|
| 8 |
Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33338-6
|
| 9 |
Graciela A. Cremaschi, Florencia Cayrol, Helena Andrea Sterle, María Celeste Díaz Flaqué, María Laura Barreiro Arcos. Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas. Pharmacological Research 2016; 109: 55 doi: 10.1016/j.phrs.2016.02.001
|
| 10 |
Helena Andrea Sterle, Florencia Cayrol, Graciela Alicia Cremaschi. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_55-1
|
| 11 |
K. J. Jerzak, J. G. Cockburn, S. K. Dhesy-Thind, G. R. Pond, K. I. Pritchard, S. Nofech-Mozes, P. Sun, S. A. Narod, A. Bane. Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study. Breast Cancer Research and Treatment 2018; 171(3): 709 doi: 10.1007/s10549-018-4844-5
|
| 12 |
Xiaoxiang Peng, Yangyang Zhang, Yanli Sun, Lujuan Wang, Wei Song, Qian Li, Ronglan Zhao. Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA‑MB‑468 cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8764
|
| 13 |
E. Cordel, N. Reix, S. Molière, C. Mathelin. Hyperthyroïdie et cancer du sein : y a-t-il une association ?. Gynécologie Obstétrique Fertilité & Sénologie 2018; 46(4): 403 doi: 10.1016/j.gofs.2018.01.010
|
| 14 |
Per Wändell, Axel C. Carlsson, Xinjun Li, Jan Sundquist, Kristina Sundquist. Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers – a cohort study of the Swedish population. Cancer Epidemiology 2020; 66: 101707 doi: 10.1016/j.canep.2020.101707
|